Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: Protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8368-8376

  Matteucci, Donatella ^a   Pistello, Mauro ^a   Mazzetti, Paola ^a   Giannecchini, Simone ^a   Del Mauro, Daniela ^a   Lonetti, Isabella ^a   Zaccaro, Lucia ^a   Pollera, Claudia ^a   Specter, Steven ^a,b   Bendinelli, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CAT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FELINE IMMUNODEFICIENCY VIRUS; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTECTION; VACCINATION;

EID: 0030864077     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8368-8376.1997     Document Type: Article

References (48)

1. Ahmad, S., B. Lohman, M. Marthas, L. Giavedoni, Z. El-Amad, N. L. Haigwood, C. J. Scandella, M. B. Gardner, P. A. Luciw, and T. Yilma. 1994. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 10:195-204.
2. Baldinotti, M., D. Matteucci, P. Mazzetti, C. Giannelli, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J. Virol. 68:4572-4579.
3. Bendinelli, M., M. Pistello, S. Lombardi, A. Poli, C. Garzelli, D. Matteucci, L. Ceccherini-Nelli, G. Malvaldi, and F. Tozzini. 1995. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8:87-112.
4. Bevan, M. J., and T. J. Braciale. 1995. Why can't cytotoxic T cells handle HIV? Proc. Natl. Acad. Sci. USA 92:5765-5767.
5. Bishop, S. A., C. R. Stokes, T. J. Gruffydd-Jones, C. V. Whiting, J. E. Humphries, R. Osborne, M. Papanastasopoulou, and D. A. Harbour. 1996. Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response. Vaccine 14:1243-1250.
6. Bolognesi, D. P. 1995. The dilemma of developing and testing AIDS vaccines, p. 301-312. In G. M. Cooper, R. G. Temin, and B. Sugden (ed.), The DNA provirus: Howard Temin's scientific legacy. American Society for Microbiology, Washington, D.C.
7. Cammarota, G., L. Da Prato, E. Nicoletti, D. Matteucci, M. Bendinelli, and M. Pistello. 1996. Quantitation of feline immunodeficiency proviruses in doubly infected cats using competitive PCR and a fluorescence-based RFLP. J. Virol. Methods 62:21-31.
8. Cammarota, G., D. Matteucci, M. Pistello, E. Nicoletti, S. Giannecchini, and M. Bendinelli. 1996. Reduced sensitivity to strain-specific neutralization of laboratory-adapted feline immunodeficiency virus after one passage in vivo: association with amino acid substitutions in the V4 region of the surface glycoprotein. AIDS Res. Hum. Retroviruses 12:173-175.
9. mac-32H. AIDS 9:223-228.
10. Diehl, L. J., C. K. Mathiason-Dubard, L. L. O'Neil, L. A. Obert, and E. A. Hoover. 1995. Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J. Virol. 69:6149-6157.
11. Elder, J. H., and T. R. Phillips. 1995. Feline immunodeficiency virus as a model for development of molecular approaches to intervention strategies against lentivirus infections. Adv. Virus Res. 45:225-247.
12. European Concerted Action on Macaque Models for AIDS Research. 1995. Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: comparison of adjuvants, doses and challenge viruses. Vaccine 13:295-300.
13. Flynn, J. N., P. Keting, M. J. Hosie, M. Mackett, E. B. Stephens, J. A. Beatty, J. C. Neil, and O. Jarrett. 1996. Env-specific CTL predominate in cats protected with feline immunodeficiency virus infection by vaccination. J. Immunol. 157:3658-3665.
14. Fultz, P. N., P. Nara, F. Barre-Sinousssi, A. Chaput, M. L. Greeberg, E. Muchmore, M. P. Kieny, and M. Girard. 1992. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science 256:1687-1690.
15. Giannecchini, S., D. Matteucci, P. Mazzetti, and M. Bendinelli. 1996. Incubation time for feline immunodeficiency virus cultures. J. Clin. Microbiol. 34:2036-2038.
16. Hilleman, M. R. 1995. Whether and when an AIDS vaccine? Nat. Med. 1:1126-1129.
17. Hirsh, V. M., T. R. Fuers, G. Sutter, M. W. Carroll, L. C. Yang, S. Goldstein, M. Piatak, W. G. Alvord, W. R. Elkins, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70:3741-3752.
18. Hosie, M. J., T. H. Dunsford, A. de Ronde, B. J. Willett, C. A. Cannon, J. C. Neil, and O. Jarrett. 1996. Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine 14:405-411.
19. Hosie, M. J., and J. N. Flynn. 1996. Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection. J. Virol. 70: 7561-7568.
20. Hosie, M. J., R. Osborne, J. K. Yamamoto, J. C. Neil, and O. Jarrett. 1995. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J. Virol. 69:1253-1255.
21. Hosie, M. J., and J. K. Yamamoto. 1995. Vaccination against FIV, p. 263-278. In B. Willett and O. Jarrett (ed.), Feline immunology and immunodeficiency. Oxford University Press, Oxford, England.
22. Israel, Z. R., P. F. Edmonson, D. H. Maul, S. P. O'Neil, S. P. Mossman, C. Thiriart, L. Fabry, O. van Opstal, C. Bruck, F. Bex, A. Burny, P. N. Fultz, J. I. Mullins, and E. A. Hoover. 1994. Incomplete protection, but suppression of viral burden, elicited by subunit simian immunodeficiency virus vaccines. J. Virol. 68:1843-1853.
23. + antiviral activity in cats infected with feline immunodeficiency virus. J. Virol. 70:2474-2480.
24. Jordan, H. L., J. Howard, W. A. Tompkins, and S. Kennedy-Stoskopf. 1995. Detection of feline immunodeficiency virus in semen from seropositive domestic cats (Felis catus). J. Virol. 69:7328-7333.
25. Lombardi, S., C. Garzelli, M. Pistello, C. Massi, D. Matteucci, F. Baldinotti, G. Cammarota, L. Da Prato, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. J. Virol. 68:8374-8379.
26. Lüke, W., C. Coulibaly, U. Dittmer, G. Voss, R. Oesterle, B. Makoschey, U. Sauermann, E. Jurkiewicz, C. Stahl-Hennig, H. Petry, and G. Hunsmann. 1996. Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaqua mulatta) against the infection with SIVmac32H grown on T cells or derived ex vivo. Virology 216:444-150.
27. Lutz, H., R. Hofmann-Lehman, K. Bauer-Pham, E. Holznagel, F. Tozzini, M. Bendinelli, G. Reubel, A. Aubert, D. Davis, B. Cox, and E. Young. 1995 FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection. Vet. Immunol. Immunopathol. 46: 103-113.
28. Mathieson, B. J. 1995. CTL to HIV-1: surrogates or sirens. Nat. Med. 1:304-305.
29. Matteucci, D., M. Pistello, P. Mazzetti, S. Giannecchini, D. Del Mauro, L. Zaccaro, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1996. Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies. J. Virol. 70:617-622.
30. Montefiori, D. C. 1993. In vitro correlates of HIV and SIV humoral immunity and infection enhancement. AIDS Res. Rev. 3:161-183.
31. Mossman, S. P., F. Bex, P. Berglund, J. Arthos, S. P. O'Neil, D. Riley, D. H. Maul, C. Bruck, P. Momin, A. Burny, P. N. Fultz, J. I. Mullins, P. Liljeström, and E. A. Hoover. 1996. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and hv a gp120 subunit vaccine. J. Virol. 70:1953-1460.
32. O'Brien, W. A., K. Grovit-Ferbas, A. Namazi, S. Ovcak-Derzic, H. J. Wang, J. Park, C. Yeramian, S. H. Mao, and J. A. Zack. 1995. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86:1082-1089.
33. Pedersen, N. C. 1993. The feline immunodeficiency virus, p. 181-223. In J. L. Levy (ed.), The Retroviridae, vol. 2. Plenum Press, New York, N.Y.
34. Pistello, M., G. Cammarota, E. Nicoletti, D. Matteucci, M. Curcio, D. Del Mauro, and M. Bendinelli. 1997. Analysis of genetic diversity and phylogenetic relationship of Italian isolates of feline immunodeficiency virus indicates high prevalence and heterogeneity of subtype B. J. Gen. Virol. 78: 2247-2257.
35. Pistello, M., S. Menzo, M. Giorgi, L. Da Prato, G. Cammarota, M. Clementi, and M. Bendinelli. 1994. Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. Mol. Cell. Probes 8:229-234.
36. Poignard, P., P. J. Klasse, and Q. J. Sattentau. 1996. Antibody neutralization of HIV-1. Immunol. Today 17:239-246.
37. Richardson, J., I. Fossati, A. Moraillon, S. Castelot, P. Sonigo, and G. Pancino. 1996. Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope. J. Gen. Virol 77:759-777.
38. Rigby, M. A., N. Mackay, G. Reid, R. Osborne, J. C. Neil, and O. Jarrett. 1996. Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein. Vaccine 14:1095-1102.
39. Sabin, A. B. 1992. Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry. Proc. Natl Acad. Sci. USA 89:8852-8855.
40. Siebelink, K. H. J., E. Tijhaar, R. C. Huisman, W. Huisman, A. deRonde, I. H. Darby, M. J. Francis, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus. 1995. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J. Virol. 69:3704-3711.
41. Stanley, S. K., M. A. Ostrowski, J. S. Justement, K. Gantt, S. Hedayati, M. Mannix, K. Roche, D. J. Schwartzentruber, C. H. Fox, and A. S. Fauci. 1996. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N. Engl. J. Med. 334:1222-1230.
42. Stott, E. J. 1991. Anti-cell antibody in macaques. Nature 353:393.
43. Strapans, S. I., B. L. Hamilton, S. E. Follansbee, T. Elbeik, P. Barbosa, R. Grant, and M. B. Feinberg. 1995. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 182:1727-1737.
44. Tozzini, F., D. Matteucci, P. Bandecchi, F. Baldinotti, K. Siebelink, A. Osterhaus, and M. Bendinelli. 1993. Neutralizing antibodies in cats infected with feline immunodeficiency virus. J. Clin. Microbiol. 31:1626-1629.
45. Verschoor, E. J., M. J. Willemse, J. G. Stam, A. L. W. van Vliet, H. Pouwels, S. K. Chalmers, M. C. Horzinek, P. J. A. Sondermeijer, W. Hesselink, and A. de Ronde. 1996. Evaluation of subunit vaccines against feline immunodeficiency virus infection. Vaccine 14:285-289.
46. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.
47. Yamamoto, J. K., H. Hansen, E. W. Ho, T. Y. Morishita, T. Okuda, T. R. Sawa, R. M. Nakamura, and N. C. Pedersen. 1989. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. JAVMA 194:213-220.
48. Yamamoto, J. K., T. Hohdatsu, R. A. Olmsted, R. Pu, H. Louie, H. A. Zochlinski, V. Acevedo, H. M. Johnson, G. A. Soulds, and M. B. Gardner. 1993. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol. 67:601-605.